(Selskabsmeddelelse 21/2025) De tekniske udfordringer er nu løst. Derfor anmoder vi om ophør af suspension af alle afdelinger. Med venlig hilsen Syd Fund Management A/S Tlf. 74 37 33 00 ...

NEW YORK, Nov. 28, 2025 (GLOBE NEWSWIRE) -- As electric vehicle adoption accelerates in the United States and around the world, home charging has become one of the most important considerations for new and existing EV owners. Today, EVDANCE, a leading provider of portable EV charging equipment, announced its official 2025 Home EV Charger Recommendations, emphasizing two key priorities for consumers: UL2594 safety-certified chargers and a major Black Friday promotion offering 20% off plus a free adapter. Wit ...

The membership of the Supervisory Board of Aktsiaselts Infortar subsidiary AS Elenger Grupp is changing. As of December, 1 2025 Priit Tamme is appointed as a member Supervisory Board based on a resolution of the sole shareholder of AS Elenger Grupp. The Supervisory Board of AS Elenger Grupp will continue with five members. Infortar operates in seven countries. the company's main fields of activity are maritime transport. energy and real estate. Infortar owns a 68.47% share in Tallink Grupp. a 100% share in ...

DENVER, Nov. 28, 2025 (GLOBE NEWSWIRE) -- Xeriant, Inc. (OTCQB:XERI) is entering a new strategic era, one that follows the same pattern that lifted SMX from a niche technology story to a global verification force in 2025. Through the elevation of Brig. Gen. (Ret.) Blaine D. Holt to president of the company’s newly formalized Factor X Research Group, Xeriant is making the same kind of structural shift, one that turns fragmented innovation into a coordinated engine capable of delivering scalable, commercial-r ...

UAB “Atsinaujinančios energetikos investicijos” (hereinafter, the “Company”) hereby informs that meeting of holders of notes of the Company, ISIN LT0000405938 (hereinafter, the “Notes”), dated 28 November 2025 approved the following proposals, provided by the Company (hereinafter, the “Proposals”): 1. The Maturity Date of the Notes is prolonged from 14 December 2025 to 15 June 2026. 2. The Interest Rate of the Notes is increased from 5.00% per annum to 8.50% per annum, as from 15 December 2025 and until the ...

WASHINGTON, Nov. 28, 2025 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. (NASDAQ:) (“ASP Isotopes” or the “Company”), an advanced materials company focused on developing technologies and processes for the production of isotopes for multiple industries, today announced the establishment of a new Photonics Chair at the University of Witwatersrand, Johannesburg (Wits University), through an endowment under a three-year donation agreement. Dr. Angela Dudley has been named as the inaugural incumbent of the new Photonics ...

TORONTO, Nov. 28, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“Quantum BioPharma”), is pleased to announce that national television network CTV News’ flagship investigative program W5 has aired Part 2 of a three-part series about Quantum Biopharma and the company’s allegations of stock market manipulation. Award-winning CTV News journalist and W5 investigative reporter Jon Woodward provides highlights of Part Two of the series in an article entitled, “‘Something w ...

Extends cash runway through at least the first half of 2028Led by Vivo Capital, Janus Henderson Investors, Coastlands Capital, Columbia Threadneedle Investments, Adage Capital Partners, and Squadron Capital Management MIAMI, Nov. 28, 2025 (GLOBE NEWSWIRE) -- Pasithea Therapeutics Corp. (“Pasithea” or the “Company”) (Nasdaq: KTTA; KTTAW), a clinical-stage biotechnology company developing PAS-004, a next-generation macrocyclic oral MEK inhibitor for the treatment of neurofibromatosis type 1-associated plexifo ...

TORONTO and HAIFA, Israel, Nov. 28, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone” or the “Company”), a preclinical-stage biotechnology company pioneering exosome-based therapies for central nervous system injuries, is pleased to announce its financial results for the third quarter ended September 30, 2025 (“Q3 2025”) and provided a corporate update on recent achievements and upcoming milestones. The Company’s unaudited condensed interim consolidated financ ...

MENLO PARK, Calif., Nov. 28, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced today that management will participate in a fireside chat at Piper Sandler’s 37th Annual Healthcare Conference on Wednesday, December 3, 2025, at 11:30 AM ET in New York, NY. A live webcast of the event can be accessed at the company’s investors page at investor.pacificbiosciences.com. A replay of the webcast will be available for at least 30 days ...